AbCellera
the opportunity access the of natural antibodies cro the immune system is a that encodes nature answers for fighting diseases and infections but it been challenging to access the billions of unique antibodies inside each is made by a single cell lately antibody finding each patient the cell that makes it powered by over antibodies created by natural immune systems benefit from selection quality assurance and optimization of approved antibody drugs are derived from natural immune systems | AbCellera
Company
Deck Type
IPO
Deck date
December 2020
Slide
7 of 38
Other recent decks by AbCellera
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io